Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Cancer Advances Inc Announces New Publication Gastrin Vaccine Improves Response To Immune Checkpoint Antibody In Murine Pancreatic Cancer By Altering The Tumor Microenvironment In The Journal Cancer Immunology Immunotherapy is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Newly approved cancer drug targets aggressive form of ‘deadly disease’
A new drug regimen for certain types of pancreatic cancer recently received approval ... according to an FDA press release. The group of patients who received the new regimen via IV infusion ... Read More
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
Paper details vaccine design optimization process of Gritstone’s “off-the-shelf” or shared neoantigen vaccine platform, SLATE ---- Discovery ... Read More
Cancer cases could increase 77% as global population balloons. These types are most common.
The release ... vaccine, cardiac arrest in young people, new CDC study finds Houston transplant surgeon accused of altering records to deny patients organs; program suspended Likelihood of cancer ... Read More
Pancreatic cancer vaccine prevents recurrence for three years in small trial
Eight patients have not had their pancreatic cancer recur for three years after their immune systems ... Center in New York City, said in a news release. Related Blood test may improve detection of ... Read More
New blood test shows high accuracy for colorectal cancer detection, study finds: ‘Not interchangeable’
A simple blood test could detect colorectal cancer ... published in The New England Journal of Medicine, included nearly 8,000 people between the ages of 45 and 84, a press release stated. Read More
Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases
During its Capital Markets Day in New ... immune response, which correlates with clinical responses in cancer patients. Nykode’s lead product candidates are VB10.16, a therapeutic vaccine ... Read More
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
Blood-based assay uses personalized tumor-informed approach designed to detect cancer ... Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new ... Read More
OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
Nantes, France – April 2, 2024 – 7:30 am CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the publication ... immune checkpoint target for cancer immunotherapy. Read More
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use
53.8% of Medical Cannabis Patients in Study Reported a Decrease on Prescription Opioid Use NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray ... Read More
Kate Middleton announces she is undergoing treatment for cancer in new video
Catherine, Princess of Wales, is in the "early stages" of chemotherapy treatment after she was diagnosed with cancer ... Kensington Palace told NBC News in response. The London Clinic told ... Read More
WHO urges increased cholera vaccine production in response to surging cases
more than double those reported in 2021," the WHO said in a press release Wednesday. Advertisement The International Coordinating Group on Vaccine Provisions, which manages the cholera vaccine ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus